0001209191-17-055827.txt : 20171004 0001209191-17-055827.hdr.sgml : 20171004 20171004162201 ACCESSION NUMBER: 0001209191-17-055827 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171002 FILED AS OF DATE: 20171004 DATE AS OF CHANGE: 20171004 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KILTS JAMES M CENTRAL INDEX KEY: 0001025094 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15787 FILM NUMBER: 171121905 MAIL ADDRESS: STREET 2: 120 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: METLIFE INC CENTRAL INDEX KEY: 0001099219 STANDARD INDUSTRIAL CLASSIFICATION: LIFE INSURANCE [6311] IRS NUMBER: 134075851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 BUSINESS PHONE: 212-578-5500 MAIL ADDRESS: STREET 1: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-10-02 0 0001099219 METLIFE INC MET 0001025094 KILTS JAMES M 200 PARK AVENUE NEW YORK NY 10166 1 0 0 0 Common Stock 2017-10-02 4 A 0 720 52.14 A 66324.3467 D Common Stock 236 I by JMK Investments 2, LP The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. The Reporting Person disclaims beneficial ownership of 76.44% of shares held by JMK Investments 2, LP, representing limited partnership interests in trusts for the benefit of each of his children. Mark A. Schuman, authorized signer 2017-10-04